Carbamylcholine
Carbamoylcholine, also known as carbachol, is a muscarinic agonist discovered in 1932. Carbamoylcholine was initially used as a treatment for migraines, induction of diuresis, and other parasympathetic effects.  Carbamoylcholine was granted FDA approval on 28 September 1972.